These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 11409487)
1. Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response? James MJ; Penglis PS; Caughey GE; Demasi M; Cleland LG Inflamm Res; 2001 May; 50(5):249-53. PubMed ID: 11409487 [TBL] [Abstract][Full Text] [Related]
2. Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors. Penglis PS; Cleland LG; Demasi M; Caughey GE; James MJ J Immunol; 2000 Aug; 165(3):1605-11. PubMed ID: 10903770 [TBL] [Abstract][Full Text] [Related]
3. Assay of cyclooxygenase-1 and 2 in human monocytes. Demasi M; Caughey GE; James MJ; Cleland LG Inflamm Res; 2000 Dec; 49(12):737-43. PubMed ID: 11211927 [TBL] [Abstract][Full Text] [Related]
4. Effects of hypoxia on monocyte inflammatory mediator production: Dissociation between changes in cyclooxygenase-2 expression and eicosanoid synthesis. Demasi M; Cleland LG; Cook-Johnson RJ; Caughey GE; James MJ J Biol Chem; 2003 Oct; 278(40):38607-16. PubMed ID: 12874281 [TBL] [Abstract][Full Text] [Related]
5. Analysis of eicosanoid mediation of the renal functional effects of hyperchloremia. Askari B; Bell-Quilley CP; Fulton D; Quilley J; McGiff JC J Pharmacol Exp Ther; 1997 Jul; 282(1):101-7. PubMed ID: 9223545 [TBL] [Abstract][Full Text] [Related]
6. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Tapiero H; Ba GN; Couvreur P; Tew KD Biomed Pharmacother; 2002 Jul; 56(5):215-22. PubMed ID: 12199620 [TBL] [Abstract][Full Text] [Related]
7. Hyaluronan-induced cyclooxygenase-2 expression promotes thromboxane A2 production by renal cells. Sun LK; Beck-Schimmer B; Oertli B; Wüthrich RP Kidney Int; 2001 Jan; 59(1):190-6. PubMed ID: 11135071 [TBL] [Abstract][Full Text] [Related]
8. Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis by thromboxane A2 in nonadherent human monocytes. Caughey GE; Pouliot M; Cleland LG; James MJ J Immunol; 1997 Jan; 158(1):351-8. PubMed ID: 8977210 [TBL] [Abstract][Full Text] [Related]
9. Prostanoid biosynthesis by blood monocytes of children with hyperprostaglandin E syndrome. Nüsing RM; Schaub TP; Klein T; Schweer H; Seyberth HW Pediatr Res; 1997 Aug; 42(2):241-6. PubMed ID: 9262230 [TBL] [Abstract][Full Text] [Related]
10. Dual acting anti-inflammatory drugs: a reappraisal. Bertolini A; Ottani A; Sandrini M Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348 [TBL] [Abstract][Full Text] [Related]
11. Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production. Tao X; Schulze-Koops H; Ma L; Cai J; Mao Y; Lipsky PE Arthritis Rheum; 1998 Jan; 41(1):130-8. PubMed ID: 9433878 [TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 production dependent upon cyclooxygenase-1 and cyclooxygenase-2 and its contradictory modulation by auranofin in rat peritoneal macrophages. Yamada M; Niki H; Yamashita M; Mue S; Ohuchi K J Pharmacol Exp Ther; 1997 May; 281(2):1005-12. PubMed ID: 9152412 [TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2-dependent prostaglandin production by peripheral blood monocytes stimulated with lipopolysaccharides isolated from periodontopathogenic bacteria. Noguchi K; Yanai M; Shitashige M; Nishihara T; Ishikawa I J Periodontol; 2000 Oct; 71(10):1575-82. PubMed ID: 11063390 [TBL] [Abstract][Full Text] [Related]
15. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide. Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505 [TBL] [Abstract][Full Text] [Related]
16. Intracellular measurement of prostaglandin E2: effect of anti-inflammatory drugs on cyclooxygenase activity and prostanoid expression. Horton JK; Williams AS; Smith-Phillips Z; Martin RC; O'Beirne G Anal Biochem; 1999 Jun; 271(1):18-28. PubMed ID: 10361000 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase and cyclo-oxygenase pathways in the inflammatory response induced by zymosan in the rat air pouch. Payá M; García Pastor P; Coloma J; Alcaraz MJ Br J Pharmacol; 1997 Apr; 120(8):1445-52. PubMed ID: 9113364 [TBL] [Abstract][Full Text] [Related]
18. Diminished production of prostaglandin E2 by monocytes of newborns is due to altered fatty acid membrane content and reduced cyclooxygenase activity. Murphy FJ; Reen DJ J Immunol; 1996 Oct; 157(7):3116-21. PubMed ID: 8816422 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview. Famaey JP Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]